UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
PAM50 Molecular Subtypes in Prostate Cancer Trials - Krishnan Patel & George Zhao ...
ASTRO 2026: 68Ga-NY096 CAIX PET/CT Eliminates Decision Uncertainty and Refines Systemic Therapy-Radiotherapy Integration In Metastatic ccRCC (NYCRRT) ASTRO 2026: Long-Term Outcomes from a Phase 2 ...
The survival rate for the majority of patients with non-muscle invasive bladder cancer (NMIBC) is favorable; however, the rates of recurrence and progression to muscle-invasive bladder cancer are ...
In this article, we assess histologically validated quantitative parameters on 18F-piflufolastat (18F-DCFPyL) prostate-specific membrane antigen (PSMA) PET and identify thresholds for differentiating ...
This study aimed to assess the efficacy and safety of different laser technologies, including the new Holmium:YAG (Ho:YAG) Magneto pulse modulation, for the endoscopic ablation of upper tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results